Mercury Systems (MRCY) Down 13.8% Since Last Earnings Report: Can It Rebound?

Mercury Systems reported fiscal Q4 2026 revenue of $289.78 million, up 6.1% year over year and 9.37% above consensus, while adjusted EPS of $0.37 was in line but down 21.3%. Record bookings of $660 million (+93.1%) lifted backlog above $1.9 billion, supporting its fiscal 2027 targets for nearly $1.1 billion in revenue and about $200 million of adjusted EBITDA. Margin pressure persisted, with adjusted EBITDA margin falling 210bps to 16.7%, but debt fell by $150 million to $441.5 million and the company expects margin improvement as legacy backlog converts.

Analysis

MRCY is transitioning from a turnaround/order-recovery narrative to an execution-and-cash-conversion test. The market is unlikely to capitalize the backlog at face value until quarterly conversion proves that higher factory utilization offsets overtime, program-estimate volatility, and elevated fixed costs. The near-term de-rating risk is therefore not demand but a failure to translate volume into incremental EBITDA and free cash flow; defense primes with more diversified program exposure, including RTX, LMT and NOC, remain cleaner ways to express the spending cycle.

The Palantir relationship is strategically useful but should not be assigned material valuation credit before measurable evidence emerges: inventory turns, on-time delivery, working-capital release, or labor-cost leverage. It potentially makes PLTR more credible in defense-manufacturing operations, but the customer economics are too small to affect PLTR estimates. For MRCY, automation can improve the 6-18 month margin path, yet implementation could initially disrupt production and consume cash, particularly while capacity is being expanded.

Consensus appears to be treating upward estimate revisions and order visibility as sufficient for a rebound. The missing issue is quality of backlog: multiyear supply-reservation orders can pull demand forward and may have lower margins or less favorable working-capital terms than investors assume. A sustainable rerating requires two consecutive quarters of expanding gross margin and free cash flow conversion, rather than simply revenue growth; absent that, MRCY risks remaining a high-multiple, low-visibility defense supplier.

Key Decisions for Investors

• Maintain MRCY as a watch-list long rather than buy the drawdown immediately. Initiate only after the next report demonstrates gross-margin expansion versus the prior quarter and operating cash flow materially exceeds capital expenditure; target a 3-6 month rerating, with thesis invalidated by EBITDA margin below management's high-teens trajectory or a reduction in full-year guidance.
• For immediate defense exposure, favor a 3-6 month pair of long RTX or LMT versus short MRCY in dollar-neutral size. The trade captures MRCY-specific manufacturing and cash-conversion risk while retaining exposure to defense demand; cover the short if MRCY demonstrates two quarters of margin expansion and backlog conversion accelerates without working-capital deterioration.
• Do not add PLTR solely on the factory-software announcement. Set an alert for disclosed deployment scale, quantified productivity outcomes, or a material expansion to other defense manufacturers; without those datapoints, the revenue contribution is unlikely to justify a separate valuation catalyst over the next 1-3 months.
• Monitor receivables, inventory and free-cash-flow conversion at the next two quarterly releases. A rising working-capital burden despite revenue growth would indicate that the order book is consuming liquidity rather than creating equity value, raising downside risk given remaining leverage.